Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04514302
What this trial is testing

Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody F(ab')2 Fragments (INOSARS) for Adult Patients With Mild COVID-19

Who this might be right for
COVID-19
TecSalud Investigación Clínica 32
Testing effectiveness (Phase 2)Study completedNCT02254421
What this trial is testing

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract

Who this might be right for
Respiratory Syncytial Virus Infection
Gilead Sciences 60
Early research (Phase 1)Study completedNCT00000833
What this trial is testing

A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableEnded earlyNCT00001069
What this trial is testing

Two Methods of Determining When to Begin or Change Anti-HIV Treatment

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,100
Post-approval studies (Phase 4)Active Not RecruitingNCT04780204
What this trial is testing

Effectiveness of Antiviral Treatment in Cirrhotic Patients with Low-level Hepatitis B Virus DNA Levels

Who this might be right for
Hepatitis B, Chronic
Asan Medical Center 600
Large-scale testing (Phase 3)Ended earlyNCT04730206
What this trial is testing

The DAWN Antivirals Trial for Ambulatory COVID-19 Patients

Who this might be right for
Covid19SARS-CoV Infection
KU Leuven 44
Early research (Phase 1)Study completedNCT04008004
What this trial is testing

EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2)

Who this might be right for
Chronic HBV Infection
Enanta Pharmaceuticals, Inc 99
Post-approval studies (Phase 4)Ended earlyNCT00386659
What this trial is testing

Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.

Who this might be right for
HIV Infection
Hospital Clinic of Barcelona 60
Testing effectiveness (Phase 2)Study completedNCT00217503
What this trial is testing

Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma

Who this might be right for
Lymphoma
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00874770
What this trial is testing

Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha and Ribavirin)

Who this might be right for
Hepatitis C Infection
Bristol-Myers Squibb 74
Early research (Phase 1)Study completedNCT00000656
What this trial is testing

A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 116
Testing effectiveness (Phase 2)Study completedNCT04507269
What this trial is testing

Study of VIR-2218 in Patients With Chronic Hepatitis B in Mainland China

Who this might be right for
Hepatitis B, Chronic
Brii Biosciences Limited 21
Large-scale testing (Phase 3)Study completedNCT02822794
What this trial is testing

Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing Regimen

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 117
Post-approval studies (Phase 4)Study completedNCT00412334
What this trial is testing

SYREN Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Non-Responder Patients With Chronic Hepatitis C (CHC) Genotype 1.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 104
Not applicableUnknownNCT04732832
What this trial is testing

HCV Reinfection in HD Patients Achieving SVR

Who this might be right for
Hepatitis C Virus InfectionHepatitis C Virus Infection, Response to Therapy ofHemodialysis Complication
National Taiwan University Hospital 350
Testing effectiveness (Phase 2)Ended earlyNCT05303909
What this trial is testing

The Immunostimulatory Effects of Gentamicin

Who this might be right for
Healthy Volunteers
Singapore General Hospital 33
Not applicableStudy completedNCT03318887
What this trial is testing

Impact of Sofosbuvir and Daclatasvir Concentration on HCV RNA

Who this might be right for
Hepatitis C
Hospices Civils de Lyon 130
Not applicableStudy completedNCT00002021
What this trial is testing

An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies

Who this might be right for
Herpes SimplexHIV Infections
Astra USA
Large-scale testing (Phase 3)Study completedNCT00301509
What this trial is testing

Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis

Who this might be right for
Liver Cirrhosis, Experimental
Casa Sollievo della Sofferenza IRCCS
Early research (Phase 1)Study completedNCT01813552
What this trial is testing

To Evaluate the Effect of Ritonavir or Omeprazole on the Pharmacokinetics of Samatasvir (IDX719) in Healthy Participants (MK-1894-006)

Who this might be right for
Chronic Hepatitis C Infection
Merck Sharp & Dohme LLC 24
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation